|
CREG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.060200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.460100E-03 |
| Normal-vs-Stage2 |
2.744800E-01 |
| Normal-vs-Stage3 |
2.697000E-01 |
| Normal-vs-Stage4 |
1.997020E-01 |
| Stage1-vs-Stage2 |
8.582200E-03 |
| Stage1-vs-Stage3 |
4.716500E-02 |
| Stage1-vs-Stage4 |
6.765800E-02 |
| Stage2-vs-Stage3 |
7.798800E-01 |
| Stage2-vs-Stage4 |
4.128000E-01 |
| Stage3-vs-Stage4 |
6.621000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.531200E-01 |
| Normal-vs-AfricanAmerican |
7.153800E-01 |
| Normal-vs-Asian |
2.839400E-01 |
| Caucasian-vs-AfricanAmerican |
7.915400E-01 |
| Caucasian-vs-Asian |
2.564600E-01 |
| AfricanAmerican-vs-Asian |
2.685600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.489200E-01 |
| Normal-vs-Female |
7.807000E-01 |
| Male-vs-Female |
4.662200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.875400E-01 |
| Normal-vs-Extreme_Weight |
3.582800E-01 |
| Normal-vs-Obese |
4.992600E-01 |
| Normal-vs-Extreme_Obese |
4.430400E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.612800E-01 |
| Normal_Weight-vs-Obese |
7.961200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.698200E-01 |
| Extreme_Weight-vs-Obese |
8.193400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.578200E-01 |
| Obese-vs-Extreme_Obese |
6.258000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.965800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.815200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.706000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.208600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.969200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.603800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.923400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.121600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.934000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.386600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.636400E-02 |
| Normal-VS-Type2 PRCC |
8.864200E-02 |
| Normal-VS-KIRP CIMP |
5.221600E-02 |
| Normal-VS-Unclassified PRCC |
5.599000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.779700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.008500E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
4.375800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.204200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.305700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.479700E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.356200E-01 |
| Normal-vs-N1 |
6.265600E-02 |
| Normal-vs-N2 |
4.310000E-01 |
| N0-vs-N1 |
2.269000E-01 |
| N0-vs-N2 |
5.412400E-01 |
| N1-vs-N2 |
9.818600E-01 |
|
|
